Key result
This review summarizes established and emerging pharmacological and nonpharmacological therapies for the management of vasodilatory shock.
Why the study?
Vasodilatory shock is a severe circulatory disorder driven by dysregulated vasodilation and reduced responsiveness to endogenous vasoconstrictors, warranting a review of its pathophysiology and therapies.
This review provides a comprehensive summary of established and emerging pharmacological and nonpharmacological therapies for the management of vasodilatory shock.
Does not support practice changes in vasodilatory shock; leaves open optimal sequencing for future trials.
Vasodilatory shock is a severe circulatory disorder characterized by excessive vasodilation, resulting in impaired tissue perfusion and organ dysfunction. The condition arises from dysregulated vasodilation and reduced vascular responsiveness to endogenous vasoconstrictors, disrupting normal vasoregulatory mechanisms. This review delves into the complex pathophysiology, clinical significance, and treatment approaches for vasodilatory shock. It offers a comprehensive summary of established and emerging pharmacological and nonpharmacological therapies. Designed for clinicians and researchers, this article consolidates critical insights to improve the understanding and management of vasodilatory shock.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2025) conducted a review in Vasodilatory shock. Pharmacological and nonpharmacological therapies was evaluated. This review summarizes established and emerging pharmacological and nonpharmacological therapies for the management of vasodilatory shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: